Purchase Order 75N94023P00830
Award Date 9/18/23
Potential Completion Date 6/9/24
Potential Value $17K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) awarded a $119,200.00 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services in support of future RNA sequencing work for NHGRI. This award is not associated with a set-aside program. Through previous federal contracts valued between $16,464 and $668,710, Norgen Biotek has provided similar exosome and extracellular RNA extraction,...
- The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute (NHGRI) awarded a firm-fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services for future RNA sequencing. The potential value of the contract is $165,000.00, and the period of performance is from the award date of June 25, 2019, to the completion date of June 24, 2021. Norgen Biotek Corp has previously provided...
- This is a purchase order contract awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Norgen Biotek Corp, a Canadian for-profit manufacturer of biotechnology products and services. The contract, valued at $149,840, is for the provision of exosome and extracellular RNA extraction, isolation, purification, and sequencing services to support clinical research studies at NIH. Norgen Biotek has previously been awarded over $1 million in...
- The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health under the Department of Health and Human Services, awarded a $156,600 firm fixed-price purchase order to Norgen Biotek Corp for small RNA characterization of urinary exosomes. This is a new purchase order with no set-aside designation, making it open to competition among all qualified contractors. Work will be performed at Norgen Biotek's facilities in Bethesda, Maryland, with an ultimate completion...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at approximately $668,710 to Norgen Biotek Corp. of Ottawa, Canada. Under the terms of the contract, Norgen Biotek will extract and isolate intact RNA exosomes from plasma samples to support an unspecified clinical study being conducted by the National Heart, Lung and Blood Institute. The original solicitation sought proposals for...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $190,000 firm fixed-price purchase order to Exonova Biosciences LLC on January 1, 2026, for scientific support services focused on inflammatory and vascular diseases. The contract, which extends through December 31, 2026, supports the Biomedical and Metabolic Imaging Branch and was awarded without full and open competition under simplified acquisition procedures. The procurement was designated as a Total Small...
- This firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services, to 10X Genomics, Inc. for the acquisition of a Single Cell 3' Kit. The $26,045.50 contract supports ongoing research by NIDDK and the National Institute of Child Health and Human Development into the molecular origins of kidney diseases such as focal...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), an institute of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $13,805 purchase order to Oxford Nanopore Technologies Inc. for two PromethION 2 Solo Starter Packs. As the prime contractor, Oxford Nanopore Technologies Inc. will deliver the requested products to the NIDDK under a firm fixed price contract running from August 16 to September 30, 2023. The place...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases awarded a $10,848.60 firm fixed-price purchase order contract to Life Technologies Corporation of Grand Island, New York. As the prime contractor, Life Technologies Corporation will provide unspecified products or services to the agency between March 15, 2019 and April 14, 2019 to support the National Institute of Diabetes and Digestive and Kidney...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $22,067.00 firm fixed price purchase order (Contract # 75N94020P00686) to 10X Genomics, Inc. to provide reagents related to COVID-19 research. The award, which does not have a set-aside designation, is in support of the NIDDK's work under the Coronavirus COVID-19 National Interest Action Code. 10X Genomics is a life sciences technology company that specializes in products and services for single-cell and...